BioSpace News Archive

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) (a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs) will be presenting at the Emerging Growth Conference on November 30, 2022.

According to Nova one advisor, the global Microfluidics market size is evaluated at USD 23.65 billion in 2022 and is expected to hit around USD 72.09 billion by 2030, growing at a CAGR of 12.40% from 2022 to 2030.

According to Nova one advisor, the global Bioinformatics market size is expected to hit around USD 45.9 billion by 2030 from valued at USD 24.7 billion in 2021 and growing at a CAGR of 16.9% from 2022 to 2030.

Kala Pharmaceuticals, Inc. announced that it has entered into a definitive agreement with a life sciences-focused investor for the sale, in a private placement priced at-the-market under Nasdaq rules, of shares of its common stock and Series E Convertible Non-Redeemable Preferred Stock in two tranches for gross proceeds of up to $31 million.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that its partner Genentech, a member of the Roche Group, has launched a Phase 2a, multicenter, open-label, single arm clinical study of RG6501 (OpRegen), a retinal pigment epithelial cell therapy.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six company-sponsored Epidiolex will be shared at the upcoming 2022 American Epilepsy Society (AES) annual meeting, which will be held December 2-6, 2022, in Nashville, TN.

Accuray Incorporated (NASDAQ: ARAY) announced today that its commitment to delivering better, faster cancer treatment technology and superior service is resulting in highly satisfied customers.

Carestream’s legacy of delivering quality medical imaging technology continues with the launch of new digital X-ray detectors that help improve clinical outcomes, while enhancements to its existing product portfolio reflect the company’s deep understanding of the radiology profession.

Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to participate in a “fireside chat” Q&A session at the 34th Annual Piper Sandler Healthcare Conference on Wednesday, November 30, 2022 beginning at 10:00 am ET.

ScreenPoint Medical is showcasing Transpara®, the world’s leading artificial intelligence (AI) breast care software, here at the 108th Annual Radiological Society of North America (RSNA) meeting, November 27-December 1, 2022 (South Hall #4141).